cardiotoxicity screening using hipsc cardiomyocytes and acea's xcelligence cardioecr sysem
Published 7 years ago • 228 plays • Length 1:15Download video MP4
Download video MP3
Similar videos
-
49:20
cardiac toxicity assessment using stem cell derived cardiomyocytes
-
7:10
innovations series with acea bioscience's xcelligence cardioecr system
-
28:27
innovations w/ed begley, jr featuring acea's rtca xcelligence cardioecr system- intv1218
-
36:26
xcelligence® rtca cardioecr system
-
57:01
webinar: exploring the role of ipsc-cardiomyocytes in drug discovery and safety assessment
-
19:39
unraveling kinase inhibitor cardiotoxicity with cardiomyocyte impedance assays
-
24:33
evaluating drug induced proarrhythmic risk using the cardioecr system
-
45:56
xcelligence training
-
4:03
acea's xcelligence dp analyzer
-
4:16
acea's xcelligence system
-
14:16
ipsc derived cardiomyocytes for predicting and removing drug cardiotoxicity - mark mercola
-
0:19
ipsc cardiomyocytes beating in a e plate
-
11:32
determining optimal cytotoxic activity of human her2neu specific cd8 t cells
-
1:01:00
predictive human induced pluripotent stem cell-derived cardiomyocyte model of cardiotoxicity
-
51:55
electrical field stimulation for the functional maturation of hipsc-cardiomyocytes
-
53:40
utilizing stem cell-derived cardiomyocytes for early safety screening - webinar presentation
-
5:26
agilent xcelligence rtca esight at aacr 2019
-
24:26
icell® cardiomyocytes & cardiotoxicity assessment
-
4:19
cytotoxicity assay with xcelligence sp - a hands-on video